2,5-di-tert-butylbenzene-1,4-diol (BHQ): SERCA Inhibition fo
2026-06-19
2,5-di-tert-butylbenzene-1,4-diol (BHQ) is a selective SERCA inhibitor that disrupts intracellular calcium homeostasis by blocking ER Ca2+-ATPase activity. Recent evidence demonstrates BHQ's capacity to enhance hematopoietic stem cell mobilization through CaMKII-STAT3-CXCR4 pathway modulation. Its well-defined solubility and storage properties support reproducible use in calcium signaling and stem cell research.
Nelfinavir Mesylate: Precision HIV-1 Protease Inhibitor in R
2026-06-18
Nelfinavir Mesylate stands at the intersection of antiviral innovation and emerging cell death modulation, enabling researchers to simultaneously target HIV-1 replication and explore ferroptosis sensitivity. This article provides actionable protocols, advanced workflow strategies, and troubleshooting insights to maximize the value of this gold-standard inhibitor from APExBIO.
Oridonin Modulates Bone Remodeling via MAPK/NF-κB and BMP-2/
2026-06-18
The referenced study demonstrates that oridonin can simultaneously inhibit thioacetamide-induced osteoclastogenesis and promote osteoblast differentiation by modulating MAPK/NF-κB and BMP-2/RUNX2 pathways. These dual effects highlight oridonin's potential as a therapeutic agent for osteoporosis, addressing both bone resorption and formation.
DDI2-NFE2L1 Axis Protects Against Ferroptosis via Proteasome
2026-06-17
This study reveals how the DDI2-mediated activation of NFE2L1 drives proteasome gene expression, safeguarding cells from ferroptotic death. The findings clarify the adaptive role of the ubiquitin-proteasome system in ferroptosis and identify the DDI2-NFE2L1 pathway as a strategic target for cancer therapy sensitization.
DMG-PEG2000-NH2: Precision Linker Design for Lipid-Based Del
2026-06-17
Explore how DMG-PEG2000-NH2, a versatile NH2-PEG derivative, enables rational, tunable lipid nanoparticle and liposomal drug delivery. This article uniquely bridges linker chemistry, application-specific protocol optimization, and recent advances in functionalized drug design.
HyperScribe™ Poly (A) Tailing Kit: Optimizing mRNA for Thera
2026-06-16
Explore how the HyperScribe™ Poly (A) Tailing Kit empowers precise mRNA stability enhancement and translation efficiency improvement for advanced molecular applications. This in-depth article highlights unique protocol optimization strategies and unpacks recent breakthroughs in in vitro mRNA therapeutics.
DOTAP-Driven Nucleic Acid Delivery: Translational Breakthrou
2026-06-16
Uncover how 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) enables advanced, targeted gene delivery for ocular disease models. This article reveals new mechanistic insights and workflow guidance for functional genomics and gene therapy applications.
Dorsomorphin (Compound C): Dual-Pathway Modulation and Redox
2026-06-15
Explore how Dorsomorphin (Compound C) enables unprecedented precision in modulating AMPK and BMP signaling, with a unique focus on redox homeostasis and assay design. Distinct from routine summaries, this article integrates mechanistic, protocol, and cross-domain insights for advanced research.
Gibberellin-Induced Autophagic Degradation of DELLA Proteins
2026-06-15
The reference study reveals that gibberellin (GA) promotes seed germination and skotomorphogenesis in Arabidopsis through an ATG8-dependent autophagic pathway targeting DELLA proteins, particularly under nutrient starvation and darkness. This work establishes a novel mechanistic link between hormone signaling and selective autophagy, expanding current understanding of plant developmental adaptation to stress.
Estradiol (A8425): Mechanisms, Benchmarks, and Protocol Inte
2026-06-14
Estradiol is a potent estrogen steroid hormone central to female physiology and multi-organ protection. This article details the molecular basis, validated effects, and practical research applications of 17 beta-estradiol, highlighting its use as a benchmark tool for estrogen receptor signaling studies.
AP1903: Precision FKBP-Binding Ligand for Conditional Cell A
2026-06-13
AP1903 sets the benchmark for precise, tunable control of FKBP fusion proteins in both in vitro and in vivo settings. Its nanomolar potency and compatibility with high-throughput workflows make it indispensable for apoptosis pathway research and conditional cell ablation studies.
GI 254023X in Preclinical Vascular and Neuroimmune Models
2026-06-12
Explore the advanced applications of GI 254023X, a selective ADAM10 inhibitor, in preclinical models of vascular integrity and neuroimmune signaling. This article delivers unique scientific analysis and protocol insights, filling a gap left by existing content.
Structural Mechanisms of FADD-Procaspase-8-cFLIP Complex in
2026-06-12
This study presents the first atomic-resolution structures of the FADD-procaspase-8-cFLIP complex, revealing how death-effector domain (DED) assemblies regulate apoptosis and necroptosis. These insights clarify molecular mechanisms underpinning cell fate decisions and provide a framework for targeted modulation of apoptosis in disease contexts.
(S)-Mephenytoin as a CYP2C19 Substrate: Organoid Workflow Ad
2026-06-11
Harnessing (S)-Mephenytoin as a gold-standard CYP2C19 substrate enables deeper insights into human-relevant drug metabolism using advanced organoid models. This guide details stepwise workflows, protocol optimizations, and troubleshooting strategies, translating recent breakthroughs into actionable laboratory practices.
UBQLN2 and HSP70 Facilitate Mitophagy via Mitochondrial Memb
2026-06-11
This study uncovers how UBQLN2 and HSP70 coordinate to promote Parkin-mediated mitophagy by facilitating rupture of the mitochondrial outer membrane, enabling selective removal of damaged mitochondria. The findings clarify a pathogenic mechanism for ALS/FTD-linked UBQLN2 mutations and shed light on mitochondrial quality control in neurodegeneration.
479 records 16/32 page Previous Next First page 上5页 1617181920 下5页 Last page